These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6378378)

  • 1. UM-SCP-1, a new human cell line derived from a prostatic squamous cell carcinoma.
    Grossman HB; Wedemeyer G; Ren L; Carey TE
    Cancer Res; 1984 Sep; 44(9):4111-7. PubMed ID: 6378378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer.
    Grenman SE; Van Dyke DL; Worsham MJ; del Rosario F; Roberts JA; McClatchey KD; Schwartz DR; Babu VR; Carey TE
    Cancer Res; 1988 Apr; 48(7):1864-73. PubMed ID: 3349465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a cell line (CUMC-3) derived from a human squamous carcinoma of the uterine cervix.
    Kim JW; Cho YH; Lyu MS; Lee CG; Jung JK; Kim SJ; Namkoong SE
    Gynecol Oncol; 1995 Apr; 57(1):47-60. PubMed ID: 7705700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell line derived from a metastasis of a human testicular germ cell tumor.
    Bronson DL; Andrews PW; Solter D; Cervenka J; Lange PH; Fraley EE
    Cancer Res; 1980 Jul; 40(7):2500-6. PubMed ID: 7388807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human prostatic adenoma and carcinoma. Transplantation of cultured cells and primary tissue fragments in "nude" mice.
    Schroeder FH; Okada K; Jellinghaus W; Wullstein HK; Heinemeyer HM
    Invest Urol; 1976 May; 13(6):395-403. PubMed ID: 57942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B.
    Carey TE; Van Dyke DL; Worsham MJ; Bradford CR; Babu VR; Schwartz DR; Hsu S; Baker SR
    Cancer Res; 1989 Nov; 49(21):6098-107. PubMed ID: 2790823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
    Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
    Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LNCaP model of human prostatic carcinoma.
    Horoszewicz JS; Leong SS; Kawinski E; Karr JP; Rosenthal H; Chu TM; Mirand EA; Murphy GP
    Cancer Res; 1983 Apr; 43(4):1809-18. PubMed ID: 6831420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of four new human non-small cell lung cancer cell lines.
    Loh PM; Clamon GH; Robinson RA; White ML; Hukku B; Rossi NP; Peterson WD
    Cancer Res; 1984 Aug; 44(8):3561-9. PubMed ID: 6744280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.
    Grénman SE; Van Dyke DL; Worsham MJ; England B; McClatchey KD; Hopkins M; Babu VR; Grénman R; Carey TE
    Int J Cancer; 1990 May; 45(5):920-7. PubMed ID: 2335395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of morphological, functional, and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas.
    Tilgen W; Boukamp P; Breitkreutz D; Dzarlieva RT; Engstner M; Haag D; Fusenig NE
    Cancer Res; 1983 Dec; 43(12 Pt 1):5995-6011. PubMed ID: 6196111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment and characterization of a xenografted human cervical carcinoma in nude mice and homologous cell line in vitro].
    Zhao X; Zhang Y; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Apr; 32(4):217-21. PubMed ID: 9596902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
    Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
    Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee.
    Lee WH
    Neurosurgery; 1990 Sep; 27(3):389-95; discussion 396. PubMed ID: 2234331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of a human cancer cell line that produces human colony-stimulating factor.
    Okabe T; Sato N; Kondo Y; Asano S; Ohsawa N; Kosaka K; Ueyama Y
    Cancer Res; 1978 Nov; 38(11 Pt 1):3910-7. PubMed ID: 308840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
    Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
    Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.
    Reid LM; Leav I; Kwan PW; Russell P; Merk FB
    Cancer Res; 1984 Oct; 44(10):4560-73. PubMed ID: 6467211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CUMC-6, a new diploid human cell line derived from a squamous carcinoma of the uterine cervix.
    Kim JW; Lee CG; Cho YH; Kim JH; Kim SJ; Kim HK; Park TC; Song SK; Namkoong SE
    Gynecol Oncol; 1996 Aug; 62(2):230-40. PubMed ID: 8751555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K; Cornelius SC; Danielpour D
    Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.
    Katzenwadel A; Schleer H; Gierschner D; Wetterauer U; Elsässer-Beile U
    Anticancer Res; 2000; 20(3A):1551-5. PubMed ID: 10928069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.